Alfa interferon reverses bone marrow fibrosis in patients with myeloproliferative diseases.

被引：0
|
作者：
Gabrail, NY
Doll, DC
机构：
[1] Gabrail Canc Ctr, Canton, OH USA
[2] Univ Missouri, Hosp & Clin, Columbia, MO USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3424
引用
收藏
页码：920A / 921A
页数：2
相关论文
共 50 条
  • [21] "ASXL1"-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms
    Gleitz, Helene F. E.
    Schneider, Rebekka K.
    HAEMATOLOGICA, 2023, 108 (05) : 1203 - 1204
  • [22] Bone marrow fibrosis in myeloproliferative neoplasms-associated myelofibrosis: Deconstructing a myth?
    Barosi, Giovanni
    Gale, Robert Peter
    LEUKEMIA RESEARCH, 2011, 35 (05) : 563 - 565
  • [23] Bone Marrow Fibrosis in Patients with Inherited Bone Marrow Failure Syndromes
    Giri, Neelam
    Maric, Irina
    Wesley, Robert
    Arthur, Diane C.
    Noel, Pierre
    Savage, Sharon A.
    Alter, Blanche P.
    BLOOD, 2009, 114 (22) : 1236 - 1237
  • [24] Phenotyping and functional studies of bone marrow stromal cells in hematological malignant diseases.
    Lopes, M.
    Pereira, J. K.
    de Melo Campos, P.
    Machado-Neto, J. A.
    Lorand-Metze, I.
    Traina, F.
    Costa, F. F.
    Saad, S. T.
    Favaro, P.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [25] Bone marrow necrosis and the Lambert-Eaton syndrome associated with interferon alfa treatment
    Kumakura, S
    Ishikura, H
    Kobayashi, S
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (03): : 199 - 200
  • [26] Mixed myelodysplastic syndrome and myeloproliferative disorder with bone marrow and pulmonary fibrosis: The role of megakaryocytes
    Rosenstingl, S
    Brouland, JP
    Zini, JM
    Tobelem, G
    Dupuy, E
    ACTA HAEMATOLOGICA, 2003, 109 (03) : 145 - 149
  • [27] The results of clinical-and-hematological as well as histomorphometric examinations in patients with chronic myeloproliferative diseases.
    Rukavitsyn, OA
    Pop, VP
    Seryakov, AP
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2003, 48 (01): : 22 - 26
  • [28] Substance P-fibronectin-cytokine interactions in myeloproliferative disorders with bone marrow fibrosis
    Rameshwar, P
    Oh, HS
    Yook, C
    Gascon, P
    Chang, VT
    ACTA HAEMATOLOGICA, 2003, 109 (01) : 1 - 10
  • [29] THE ROLE OF IGFB6 IN THE PATHOGENESIS OF BONE MARROW (BM) FIBROSIS IN MYELOPROLIFERATIVE DISEASE
    Longhitano, L.
    Tibullo, D.
    Giallongo, C.
    Di Rosa, M.
    Romano, A.
    Volti, G. Li
    Palumbo, G. A.
    Liso, A.
    HAEMATOLOGICA, 2020, 105 : S82 - S82
  • [30] PLATELET-DERIVED MITOGENIC ACTIVITY AND BONE-MARROW FIBROSIS IN MYELOPROLIFERATIVE DISORDERS
    ROMANO, M
    VIERO, P
    CORTELLAZZO, S
    BARBUI, T
    DONATI, MB
    POGGI, A
    HAEMOSTASIS, 1990, 20 (03) : 162 - 168
12345